CytoDyn (CYDY) Dividends payables (2019 - 2026)
CytoDyn's (CYDY) quarterly Dividends payables came in at $9.4 million in Q1 2026, up 18.72% YoY from $7.9 million in Q1 2025, and up 4.04% on a QoQ basis from $9.0 million in Q4 2025.
CytoDyn (CYDY) Dividends payables (2019 - 2026) Analysis & Trends
CytoDyn (CYDY) has 8 years of Dividends payables data on file, last reported at $9.4 million in Q1 2026.
- Quarterly Dividends payables rose 18.72% year-over-year to $9.4 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $9.4 million (up 18.72% YoY) and the FY2025 annual result came in at $8.3 million, up 21.76% from the prior year.
- Dividends payables climbed to $9.4 million in Q1 2026, from $9.0 million in the prior quarter.
- In the past five years, Dividends payables ranged from a high of $9.4 million in Q1 2026 to a low of $3.6 million in Q1 2022.
- A 5-year average of $6.5 million and a median of $6.4 million in 2024 frame the typical range for Dividends payables.
- Annual changes were most pronounced in 2022 — Dividends payables surged 63.22% — and 2023, when it increased 14.26%.
- Tracing CYDY's Dividends payables over 5 years: stood at $5.3 million in 2022, then gained by 14.26% to $6.0 million in 2023, then advanced by 24.52% to $7.5 million in 2024, then gained by 19.64% to $9.0 million in 2025, then climbed by 4.04% to $9.4 million in 2026.
- The last three Dividends payables figures came in at $9.4 million (Q1 2026), $9.0 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | CytoDyn | 258.01 Mn | 258.01 Mn | - | 9.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 9.38 Mn |
| Nov 30, 2025 | 9.01 Mn |
| Aug 31, 2025 | 8.64 Mn |
| May 31, 2025 | 8.27 Mn |
| Feb 28, 2025 | 7.90 Mn |
| Nov 30, 2024 | 7.53 Mn |
| Aug 31, 2024 | 7.16 Mn |
| May 31, 2024 | 6.79 Mn |
| Feb 29, 2024 | 6.42 Mn |
| Nov 30, 2023 | 6.05 Mn |
| Aug 31, 2023 | 5.68 Mn |
| May 31, 2023 | 5.31 Mn |
| Feb 28, 2023 | 5.42 Mn |
| Nov 30, 2022 | 5.29 Mn |
| Aug 31, 2022 | 4.36 Mn |
| May 31, 2022 | 3.98 Mn |
| Feb 28, 2022 | 3.64 Mn |
| Nov 30, 2021 | 3.48 Mn |
| Aug 31, 2021 | 3.07 Mn |
| May 31, 2021 | 2.65 Mn |